Valrubicin 56124-62-0
| Systematic (IUPAC) name: |
2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-({2,3,6-trideoxy-3-[(trifluoroacetyl)amino]hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethyl pentanoate |
| Valrubicin CAS number: |
56124-62-0 |
| ATC code: |
L01DB09 |
| PubChem: |
41744 |
| DrugBank: |
APRD00662 |
| Formula: |
C34H36N1O13 |
| Molecular mass: |
723.644 g/mol |
| Valrubicin Assay/Purity: |
Typically NLT 98% |
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.
